Politics

US Congress
#Investment #Politics #United States #US Food and Drug Administration (FDA)

After the midterms, biopharma needs more than a policy forecast

A Democratic Congress will likely sharpen oversight of the FDA and drug pricing, but the most consequential choices for drug developers in 2027 will still be made in clinical trial protocols, financing plans and portfolio reviews.  Washington has had a leadership change, but the development equation has not.  The November… Read More

#Exclusive Content #Opinion

US science protest
#Drug discovery #Funding #National Institutes of Health (NIH) #Politics #United States

Researchers challenge NIH screening of scientific research grants

US researchers have filed a class action lawsuit challenging the National Institutes of Health’s (NIH) policy of blocking grants to censor views it disagrees with, on everything from DEI to gender identity to climate change.  The plaintiffs are represented by the American Civil Liberties Union, the ACLU… Read More

#Editor's Choice #News #Trending News

#GlobalData #Investment #Pharmaceutical industry #Politics #Tariffs #UK #United States

Is US foreign policy uncertainty strengthening confidence in the UK?

The recent UK-US policy developments are reshaping global pharmaceutical investment and launch strategies, according to intelligence platform GlobalData.  In December 2025, the UK announced a landmark pharmaceuticals agreement with the US, granting UK-made medicines and medical technologies tariff-free access to the US market for at least three years.   Alongside this,… Read More

#Business & Investment #News #Trending News

#European Union #GlobalData #Pharmaceutical industry #Politics #United States

Experts weigh the impact of Trump’s proposed tariff on pharma

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200-250% tariff on drug imports, which could significantly increase prices and reduce profit margins.   While the tariffs are set to be announced soon, a grace period of 12 to 18 months has been indicated before they… Read More

#Business & Investment #News #Trending News

Downing Street, London, UK
#Life sciences #Pharmaceutical industry #Politics #UK government

Pharma and UK government continue to debate drug prices

A “battle” between the UK government and the pharmaceutical industry over drug prices has forced the government to delay publication of its plan for the life sciences, according to The Financial Times.  The release of the life sciences review, initially scheduled for the start of this week, was delayed in… Read More

#Business & Investment #News #Trending News

#Biopharmaceuticals #Generics #Politics #Small molecules #United States

Trump directive aims to cut costs of prescription drugs

US President Trump has signed an executive order designed to lower the cost of prescription drug prices, which includes a win for manufacturers of small molecule drugs.  The order comes one day after the Trump administration instituted a national security report into the pharmaceutical industry, which is likely to be… Read More

#Business & Investment #News #Trending News

#Funding #National Institutes of Health (NIH) #Politics #Research and development

From the Editor: Science under threat

It seems rather obvious, and somewhat unfair to DDW’s readers – considering how much he has been in the news recently – to talk more about President Donald Trump and specifically his decision to cut billions of dollars in funding to the National Institutes of Health (NIH).  The decision comes on… Read More

#Exclusive Content #Opinion

Stand Up for Science, US, March 2025
#Academic #Aix-Marseille Université #Europe #Institut Pasteur #Politics #United States #Vrije Universiteit Brussel

European universities offer scientific refuge to US researchers

Several prestigious European universities are opening their doors to American scientific researchers to provide refuge from what they call “attacks on scientific facts and against researchers”.  The Vrije Universiteit Brussel (VUB) is opening 12 postdoctoral positions for international researchers, which are open to American researchers… Read More

#News #Trending News

National Institutes of Health
#Funding #National Institutes of Health (NIH) #Politics

NIH cuts billions in funding for medical research

The Trump administration in the US has announced plans to cut billions of dollars in funding for costs related to medical research funding in universities, hospitals and other scientific institutions.  These grants include payments for “indirect costs,” defined as “facilities” and “administration”, which cost up to $9… Read More

#News #Trending News

World Health Organization
#Big pharma #Drug development #Opinion #Politics #World Health Organization

How will a Trump withdrawal from the WHO impact drug development?

In one of his first acts as President, Donald Trump signed an executive order to withdraw the US from the World Health Organization (WHO). DDW’s Megan Thomas spoke with three industry leaders to understand the impact this will have on the drug development sector. Cell and gene therapy According to… Read More

#Business & Investment #Exclusive Content #Opinion #Regulatory

#Finance #Funding #Investment #Politics #Private investment #UK government

New DDW Highlights episode: 4 November 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week that saw a second monoclonal antibody rejected by UK… Read More

#News

#Finance #Funding #Investment #Politics #Private investment #UK government

This week in drug discovery (28 Oct – 1 Nov) 

News round-up for 28 Oct – 1 Nov by DDW Senior Digital Content Editor Diana Spencer. In a week that saw a second monoclonal antibody rejected by UK regulator NICE, antibodies have been high on the news agenda. More positively, a new indication for Fasenra was approved in… Read More

#News

#Finance #Funding #Investment #Politics #Private investment #UK government

New DDW Highlights episode: 29 October 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With a presidential election just round the corner in the US and… Read More

#News

#Finance #Funding #Investment #Politics #Private investment #UK government

This week in drug discovery (21-25 October) 

News round-up for 21-25 October by DDW Senior Digital Content Editor Diana Spencer. With a presidential election just round the corner in the US and a new UK budget on the way, financial support for life sciences is high on the agenda, so the news round-up this week… Read More

#News